Unternehmen Blue Water Ventures International, Inc. Other OTC
Aktien
BWVI
US09609E1055
BWVI
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Neilank K. Jha
CEO | Chief Executive Officer | - | 12.12. |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
Chadwick Harman
COO | Chief Operating Officer | - | - |
Julian Bailes
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anish Tuteja
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Zapolin
PRN | Corporate Officer/Principal | - | - |
Aric Logsdon
PRN | Corporate Officer/Principal | - | 29.11.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bruce Cassidy
BRD | Director/Board Member | 74 | - |
Michael Gurin
BRD | Director/Board Member | - | - |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
Neilank K. Jha
CEO | Chief Executive Officer | - | 12.12. |
Julian Bailes
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chadwick Harman
COO | Chief Operating Officer | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 276 427 437 | 68 797 013 ( 24,89 %) | 0 | 24,89 % |
Aktie B | 0 | 161 700 | 0 | 0 |
Unternehmenskontakt
Psycheceutical Bioscience, Inc.
515 East Las Olas Boulevard Suite 120
33301, Fort Lauderdale
+
http://www.psycheceutical.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+49.41% | 57.87 Mrd. | |
+41.65% | 40.25 Mrd. | |
-6.72% | 39.94 Mrd. | |
-5.96% | 28.54 Mrd. | |
+12.99% | 26.4 Mrd. | |
-19.82% | 19.33 Mrd. | |
+32.35% | 12.4 Mrd. | |
-0.08% | 12.23 Mrd. | |
+25.18% | 12.2 Mrd. |